Effects of pregnancy on the pharmacokinetics and pharmacodynamics of Glyburide [glibenclamide] - control group

Trial Profile

Effects of pregnancy on the pharmacokinetics and pharmacodynamics of Glyburide [glibenclamide] - control group

Recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 01 May 2007

At a glance

  • Drugs Glibenclamide (Primary)
  • Indications Gestational diabetes; Type 2 diabetes mellitus
  • Focus Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 01 May 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top